| scholarly article | Q13442814 |
| P356 | DOI | 10.1124/MOL.110.064055 |
| P8608 | Fatcat ID | release_hikipnyrmrg3jp7ph6mc2dcxwe |
| P932 | PMC publication ID | 2912054 |
| P698 | PubMed publication ID | 20421347 |
| P5875 | ResearchGate publication ID | 43345555 |
| P50 | author | Farzin Farzaneh | Q40658885 |
| Gwyn T Williams | Q61054638 | ||
| P2093 | author name string | Mirna Mourtada-Maarabouni | |
| Anwar M Hasan | |||
| P2860 | cites work | mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E | Q24301780 |
| Classification of gas5 as a multi-small-nucleolar-RNA (snoRNA) host gene and a member of the 5'-terminal oligopyrimidine gene family reveals common features of snoRNA host genes | Q24522827 | ||
| Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor | Q24650793 | ||
| TOR signaling in growth and metabolism | Q27860757 | ||
| The Ki-67 protein: from the known and the unknown | Q28143714 | ||
| A mammalian gene with introns instead of exons generating stable RNA products | Q28273163 | ||
| Upstream and downstream of mTOR | Q28277365 | ||
| Immunopharmacology of rapamycin | Q28285198 | ||
| Genes specifically expressed at growth arrest of mammalian cells | Q28297811 | ||
| Participation of p53 protein in the cellular response to DNA damage | Q29618319 | ||
| Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin | Q29620399 | ||
| Improved method for computing potential doubling time from flow cytometric data | Q30578502 | ||
| Forward genetics in mammalian cells: functional approaches to gene discovery | Q30763509 | ||
| The use of gene function to identify the rate-limiting steps controlling cell fate | Q31035770 | ||
| Temsirolimus | Q33377310 | ||
| The host gene for intronic U17 small nucleolar RNAs in mammals has no protein-coding potential and is a member of the 5'-terminal oligopyrimidine gene family | Q33775140 | ||
| The coordinate regulation of the p53 and mTOR pathways in cells | Q33840457 | ||
| Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization | Q33920766 | ||
| The gas 5 gene shows four alternative splicing patterns without coding for a protein | Q33923333 | ||
| Glucocorticoids in T cell development and function*. | Q33932702 | ||
| Translational control of malignancy: the mRNA cap-binding protein, eIF-4E, as a central regulator of tumor formation, growth, invasion and metastasis | Q33992131 | ||
| Synthesis of the translational apparatus is regulated at the translational level | Q34058830 | ||
| Quality control of eukaryotic mRNA: safeguarding cells from abnormal mRNA function | Q34658630 | ||
| Growth arrest in human T-cells is controlled by the non-coding RNA growth-arrest-specific transcript 5 (GAS5). | Q34763432 | ||
| mTOR, translational control and human disease. | Q36013966 | ||
| Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E | Q36827075 | ||
| Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment | Q36844334 | ||
| Targeting the mTOR signaling network in cancer. | Q36955694 | ||
| Sarcophine-diol, a Chemopreventive Agent of Skin Cancer, Inhibits Cell Growth and Induces Apoptosis through Extrinsic Pathway in Human Epidermoid Carcinoma A431 Cells | Q37109455 | ||
| Mammalian target of rapamycin as a target in hematological malignancies | Q37227074 | ||
| mTOR-raptor binds and activates SGK1 to regulate p27 phosphorylation | Q39969679 | ||
| Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38. | Q40054340 | ||
| Effects of silymarin on the spontaneous proliferation and cell cycle of human peripheral blood leukemia T cells | Q40145522 | ||
| Characterization of a glucocorticoid-sensitive human lymphoid cell line | Q40500344 | ||
| Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses | Q40643579 | ||
| Regulation and expression of a growth arrest-specific gene (gas5) during growth, differentiation, and development | Q40655817 | ||
| Molecular failure of apoptosis: inappropriate cell survival and mutagenesis? | Q40972997 | ||
| Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin | Q41412030 | ||
| Isolation of genes controlling apoptosis through their effects on cell survival. | Q42225487 | ||
| Effects of nutrient deprivation and differentiation on the expression of growth-arrest genes (gas and gadd) in F9 embryonal carcinoma cells | Q42989552 | ||
| Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin | Q44189760 | ||
| The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells. | Q45110090 | ||
| The gas5 gene is disrupted by a frameshift mutation within its longest open reading frame in several inbred mouse strains and maps to murine chromosome 1. | Q52531629 | ||
| Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes | Q52833019 | ||
| Activation of T and B lymphocytes by insoluble phytomitogens | Q68991405 | ||
| Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation | Q74595877 | ||
| SnapShot: mTOR signaling | Q80193487 | ||
| Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization. | Q105219584 | ||
| P433 | issue | 1 | |
| P921 | main subject | sirolimus | Q32089 |
| P304 | page(s) | 19-28 | |
| P577 | publication date | 2010-04-26 | |
| P1433 | published in | Molecular Pharmacology | Q1943386 |
| P1476 | title | Inhibition of human T-cell proliferation by mammalian target of rapamycin (mTOR) antagonists requires noncoding RNA growth-arrest-specific transcript 5 (GAS5). | |
| P478 | volume | 78 |
| Q35027409 | 28S rRNA is inducibly pseudouridylated by the mTOR pathway translational control in CHO cell cultures |
| Q37856379 | A critical role for non-coding RNA GAS5 in growth arrest and rapamycin inhibition in human T-lymphocytes |
| Q39029178 | A role for H/ACA and C/D small nucleolar RNAs in viral replication |
| Q94526828 | Aberrant LncRNA Expression in Leukemia |
| Q47322610 | Aberrant lncRNA Expression in Multiple Myeloma |
| Q61446195 | Altered expression of long non-coding RNA GAS5 in digestive tumors |
| Q61054146 | Are snoRNAs and snoRNA host genes new players in cancer? |
| Q36317592 | Biological significance of long non-coding RNA FTX expression in human colorectal cancer |
| Q34789303 | Conserved sequence-specific lincRNA-steroid receptor interactions drive transcriptional repression and direct cell fate |
| Q51764928 | Cytoplasmic functions of long noncoding RNAs. |
| Q28727049 | Defining an EPOR- regulated transcriptome for primary progenitors, including Tnfr-sf13c as a novel mediator of EPO- dependent erythroblast formation |
| Q47102852 | Expression Profiling of Long Noncoding RNA Splice Variants in Human Microvascular Endothelial Cells: Lipopolysaccharide Effects In Vitro. |
| Q47287055 | From biomarkers to therapeutic targets-the promises and perils of long non-coding RNAs in cancer |
| Q33690709 | GAS5 long non-coding RNA in malignant pleural mesothelioma. |
| Q27309063 | Generation of a mouse model with down-regulated U50 snoRNA (SNORD50) expression and its organ-specific phenotypic modulation |
| Q42860001 | Growth arrest on inhibition of nonsense-mediated decay is mediated by noncoding RNA GAS5. |
| Q37043025 | Harnessing autophagy for cell fate control gene therapy |
| Q34518964 | Human nonsense-mediated RNA decay initiates widely by endonucleolysis and targets snoRNA host genes |
| Q47095833 | Identification and validation long non-coding RNAs of oral squamous cell carcinoma by bioinformatics method |
| Q41922550 | Impact of sequencing depth and read length on single cell RNA sequencing data of T cells. |
| Q26752457 | Long Non-Coding RNAs As Potential Novel Prognostic Biomarkers in Colorectal Cancer |
| Q37396212 | Long non-coding RNA GAS5 controls human embryonic stem cell self-renewal by maintaining NODAL signalling. |
| Q33684959 | Long non-coding RNA GAS5 inhibits cell proliferation, induces G0/G1 arrest and apoptosis, and functions as a prognostic marker in colorectal cancer |
| Q92518457 | Long non-coding RNA GAS5 promotes PC12 cells differentiation into Tuj1-positive neuron-like cells and induces cell cycle arrest |
| Q52681008 | Long non-coding RNA Gas5 regulates proliferation and apoptosis in HCS-2/8 cells and growth plate chondrocytes by controlling FGF1 expression via miR-21 regulation. |
| Q36085374 | Long non-coding RNA growth arrest-specific transcript 5 in tumor biology |
| Q34616243 | Long non-coding RNAs and control of gene expression in the immune system |
| Q41694305 | Long non-coding RNAs in B-cell malignancies: a comprehensive overview. |
| Q37139037 | Long non-coding RNAs in haematological malignancies. |
| Q28070169 | Long non-coding RNAs in normal and malignant hematopoiesis |
| Q38239035 | Long non-coding RNAs in the regulation of the immune response |
| Q47848636 | Long noncoding RNA identification in lymphoma |
| Q98460378 | Long noncoding RNA-GAS5 retards renal fibrosis through repressing miR-21 activity |
| Q35747814 | Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets |
| Q38200054 | Long noncoding RNAs: emerging stars in gene regulation, epigenetics and human disease. |
| Q38703098 | Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy |
| Q58093528 | Loss of GAS5 tumour suppressor lncRNA: an independent molecular cancer biomarker for short-term relapse and progression in bladder cancer patients |
| Q35217325 | Low expression of lncRNA-GAS5 is implicated in human primary varicose great saphenous veins |
| Q50645608 | Low expression of long non-coding RNA GAS5 is associated with poor prognosis of patients with thyroid cancer. |
| Q26801277 | Molecular and Cellular Mechanisms of Action of Tumour Suppressor GAS5 LncRNA |
| Q50041769 | Multiplatform plasma metabolic and lipid fingerprinting of breast cancer: A pilot control-case study in Colombian Hispanic women. |
| Q47694631 | New Challenge: Mitochondrial Epigenetics? |
| Q89148846 | Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application |
| Q39185393 | Non-coding RNAs: the dark side of nuclear-mitochondrial communication |
| Q39214034 | Rapamycin induces apoptosis when autophagy is inhibited in T-47D mammary cells and both processes are regulated by Phlda1. |
| Q38999344 | Regulation of apoptosis by long non-coding RNA GAS5 in breast cancer cells: implications for chemotherapy |
| Q38095498 | Role of microRNAs and long-non-coding RNAs in CD4(+) T-cell differentiation. |
| Q36346331 | The Long Noncoding RNA IFNG-AS1 Promotes T Helper Type 1 Cells Response in Patients with Hashimoto's Thyroiditis |
| Q38748127 | The Regulatory Role of Long Noncoding RNAs in Cancer Drug Resistance. |
| Q38658525 | The growth arrest-specific transcript 5 (GAS5): a pivotal tumor suppressor long noncoding RNA in human cancers |
| Q36391951 | The hallmarks of cancer: a long non-coding RNA point of view. |
| Q35242019 | The long non-coding RNA GAS5 cooperates with the eukaryotic translation initiation factor 4E to regulate c-Myc translation |
| Q35151254 | The long noncoding RNA SPRY4-IT1 increases the proliferation of human breast cancer cells by upregulating ZNF703 expression |
| Q97072562 | The role of Long Non-Coding RNAs (lncRNAs) and downstream signaling pathways in Leukemia progression |
| Q40462144 | Upregulation of long noncoding RNA TMEVPG1 enhances T helper type 1 cell response in patients with Sjögren syndrome. |
| Q35591103 | lncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer |
Search more.